Shuting Han

Gastrointestinal Medical oncologist @ National Cancer Center Singapore; NMRC research training fellow; immuno-oncology enthusiast

[Shuting Han @ShutingHan2]

@yahwee_t @NatRevDrugDisc Thanks @yahwee_t very nice review!

[Dr Sophia Wong @sophiawongyn]

✅Successfully treated (& discharged!) the first solid cancer #celltherapy #TIL @IovanceBio pt in #Asia #Singapore @nccsingapore

Thank you to all doctors, nurses, coordinators from #Haematology, #ICU, #InfectiousDisease #StemCell lab @mysgh @SingHealthSG - epitome of #teamwork!

[Shuting Han @ShutingHan2]

@LancetGastroHep Such a beautiful illustration of aspirin fighting cancer ! 😍

[The Lancet Gastroenterology & Hepatology @LancetGastroHep]

The March issue of The Lancet Gastroenterology & Hepatology is out now at https://t.co/bK6A0hWWqa!

Content includes: alcohol & cancer risk, colorectal cancer, inflammatory bowel disease, appendicitis, MASLD, viral hepatitis + more...

#GITwitter #LiverTwitter #MedTwitter

[Raghav Sundar @sundar__raghav]

At #ascogi 2025. So excited to listen to the Keynote by @PamelaKunzMD on inclusive medicine and science. Such an apt talk for today's world and changes. 😍

[Shuting Han @ShutingHan2]

Very proud of @tohhc John Chia Chee Kian and many others (across 11 countries and 66 sites) for bringing this trial to completion after >15 years of hard work and perseverance! A trial started in national cancer centre singapore 🇸🇬 just happy to be part of the story 🥳

[Gopal Iyer @DrGopalIyer]

Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial - The Lancet Gastroenterology & Hepatology https://t.co/rPSYhiMTfR
Amazing work led by my colleagues!!

[The Lancet Gastroenterology & Hepatology @LancetGastroHep]

New research - Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial

https://t.co/Tg0iWVeNV0

#GITwitter #OncTwitter #MedTwitter @OncoAlert

[Kai-Keen Shiu @KaiKeenShiu]

Fantastic to meet exciting generation of clinical trialists-scientists + make new friends with 🌎🌍🌏 experts #ESMOASIA24 @myESMO
Collaborative ideas across tumour types @EvelynWongYT @ShutingHan2 @ryanhuey @CathyEngMD @PamelaKunzMD @herbloong @tompowles1 @HaanenJohn et al 🤝🤝

[Kai-Keen Shiu @KaiKeenShiu]

Arrived in #Singapore @apgcs_summit to give an update on IO for MSI-H CRC and some hope for patients living with MSS CRC too. Judging by today’s UGI session/MDT debates with @sundar__raghav, @Shaheenah1 et al, I’m looking forward to be challenged! @ShutingHan2 @iaintan_mdphd 🧐

[Evelyn Wong @EvelynWongYT]

Fact, #gioncologists are cool. A great honour to be part of the global #GI #oncology community! Truly appreciative of our friends from afar coming to 🇸🇬! Thank you @myESMO #ESMOAsia23 #NCCSNCIS

@ShutingHan2
@sundar__raghav
@GPentheroudakis
@DucreuxMichel
@dr_robertwalsh

[Evelyn Wong @EvelynWongYT]

⚡️Truly an excellent discussion by @LizzySmyth1 @#ESMO23.
💥 KEYNOTE 585 & MATTERHORN - adding immunotherapy as neoadjuvant therapy in locally advanced gastric and GEJ tumors.

🇩🇪 microbiome or the oncologists - why do Germans do FLOT better! 😁

[Raghav Sundar @sundar__raghav]

Grateful for the opportunity to discuss important data at #ESMO2023 on the rapidly growing role of immunotherapy in gastrointestinal cancer. Understanding tumor biology is key. @ChiaraCrem1 @FilippoPietran4 @LizzySmyth1 @MyriamChalabi @KlempnerSam @SaraLonardi1 @PamelaKunzMD

[APGCS2026 @apgcs_summit]

@Shaheenah1 @tohhc @pierce_chow
@sundar__ragha @ShutingHan2 @iaintan_mdphd

[APGCS2026 @apgcs_summit]

The APGCS 2023 committee members welcome you all to attend the 10th Asia-Pacific Gastroenterology Cancer Summit happening on 18th & 19th August, 2023 in Singapore!
Block Your Calendars and Save the Date!
@Shaheenah1 @tohhc @pierce_chow
@sundar__ragha @ShutingHan2 @iaintan_mdphd

[Frontiers - Genetics @FrontGenetics]

New Research: The distinct clinical trajectory, metastatic sites, and immunobiology of microsatellite-instability-high cancers: Microsatellite-instability-high (MSI-H) cancers form a spectrum of solid organ tumors collectively known as Lynch… https://t.co/OJTSVFgReq #Genetics

[APGCS2026 @apgcs_summit]

Prof. Toh Han Chong, APGCS Committee and Deputy Director, National Cancer Centre, Singapore, welcoming speech during the 1st day of APGCS 2022!

#apgcs2022

[Evelyn Wong @EvelynWongYT]

#happeningnow 1st SingHealth Peritoneal Surface Oncology Conference in 🇸🇬!. Congrats to @JohnnyOngCA @Jolenewongsm @ChiaClaramae on the successful opening! #SPRinT Plenarytalk: Prof Med.Beate.Rau on setting up a comprehensive peritoneal centre 💥💥

[Avraham Z. Cooper, MD 🩺 @AvrahamCooperMD]

What it looks like when a T cell DESTROYS a cancer cell 🤯

#MedTwitter
https://t.co/2qdAnsKsYK

[Iain Tan, NCCS/GIS/Duke-NUS/STCC @iaintan_mdphd]

Delighted to work with @shyam_lab, @SabineTejpar, Joanito & many talented colleagues on our paper, using insights from single-cell & bulk -omics to propose an update to CMS classification of colorectal cancer, in @NatureGenet 1/
https://t.co/kStHkikbCh